Concepedia

Andreas Wicki

AW

Statistics

Publications

48

Citations

3.4K

H-Index

31

Active since

1985

Affiliations

University Hospital of Basel(Current)

University of Basel

University of Bern

University Hospital of Zurich

University of Zurich

Andreas Wicki is an author at University Hospital of Basel specializing in medicine, oncology, and cancer research.

ORCID

Top concepts

Publications per year

1985–2025

48

Publications

48

Tumor invasion in the absence of epithelial-mesenchymal transition: Podoplanin-mediated remodeling of the actin cytoskeleton

Andreas Wicki, François Lehembre, Nikolaus Wick et al. · Cancer Cell · 2006 · 582 citations · Full text

, , +12

Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study

Christoph Mamot, Reto Ritschard, Andreas Wicki et al. · The Lancet Oncology · 2012 · 233 citations

, , +7

Systemic inflammation in a melanoma patient treated with immune checkpoint inhibitors—an autopsy study

Viktor H. Koelzer, Sacha I. Rothschild, Deborah Zihler et al. · Journal for ImmunoTherapy of Cancer · 2016 · 196 citations · Full text

NCAM‐induced focal adhesion assembly: a functional switch upon loss of E‐cadherin

François Lehembre, M. Deniz Yilmaz, Andreas Wicki et al. · The EMBO Journal · 2008 · 185 citations · Full text

[Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting.

Damian Wild, Martin Béhé, Andreas Wicki et al. · PubMed · 2006 · 171 citations

1–5 of 48